brl 42810 has been researched along with Chronic Disease in 12 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 12 patients with hematologic malignancies, we performed a prospective study to determine the effectiveness of nucleoside analogues in the pre-emptive therapy of chemotherapy-induced HBV reactivation." | 2.72 | A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues. ( Acar, K; Aki, Z; Bozdayi, G; Haznedar, R; Sucak, GT; Yağci, M, 2006) |
| " The prodrugs valacyclovir and famciclovir offer easier, less-frequent dosing than required for acyclovir." | 2.41 | Progress in meeting today's demands in genital herpes: an overview of current management. ( Patel, R, 2002) |
| "Zoster-associated pain has a complex pathophysiology that begins with viral damage and increased sensitization of peripheral sensory neurons." | 2.41 | Understanding pain in herpes zoster: an essential for optimizing treatment. ( Wood, M, 2002) |
| " Famciclovir and valacyclovir offer improved oral bioavailability and convenient oral dosing schedules but are more expensive than acyclovir." | 2.41 | Treatment of common cutaneous herpes simplex virus infections. ( Emmert, DH, 2000) |
| "The pharmacokinetic profile of penciclovir was determined after a single 500-mg dose of its oral precursor, famciclovir, in 9 healthy volunteers and in 14 patients with chronic hepatic disease." | 1.29 | Pharmacokinetics of famciclovir in subjects with chronic hepatic disease. ( Audet, PR; Boike, SC; Fairless, A; Freed, MI; Ilson, BE; Jorkasky, DK; Pue, M; Zariffa, N, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sackel, DJ | 1 |
| Castano, E | 1 |
| Cohen, EJ | 1 |
| Flacke, GL | 1 |
| Schmidt-Küntzel, A | 1 |
| Marker, L | 1 |
| Patel, R | 1 |
| Wood, M | 1 |
| Gilden, DH | 1 |
| Cohrs, RJ | 1 |
| Hayward, AR | 1 |
| Wellish, M | 1 |
| Mahalingam, R | 1 |
| Wassilew, S | 1 |
| Yağci, M | 2 |
| Acar, K | 2 |
| Sucak, GT | 1 |
| Aki, Z | 1 |
| Bozdayi, G | 1 |
| Haznedar, R | 1 |
| Schalm, SW | 1 |
| de Man, RA | 1 |
| Heijtink, RA | 1 |
| Niesters, HG | 1 |
| Boike, SC | 1 |
| Pue, M | 1 |
| Audet, PR | 1 |
| Freed, MI | 1 |
| Fairless, A | 1 |
| Ilson, BE | 1 |
| Zariffa, N | 1 |
| Jorkasky, DK | 1 |
| Main, J | 1 |
| Brown, JL | 1 |
| Howells, C | 1 |
| Galassini, R | 1 |
| Crossey, M | 1 |
| Karayiannis, P | 1 |
| Georgiou, P | 1 |
| Atkinson, G | 1 |
| Thomas, HC | 1 |
| Emmert, DH | 1 |
| Landow, K | 1 |
5 reviews available for brl 42810 and Chronic Disease
| Article | Year |
|---|---|
Progress in meeting today's demands in genital herpes: an overview of current management.
Topics: 2-Aminopurine; Acute Disease; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antibodies, V | 2002 |
Understanding pain in herpes zoster: an essential for optimizing treatment.
Topics: 2-Aminopurine; Acyclovir; Analgesics; Antiviral Agents; Chronic Disease; Clinical Trials as Topic; F | 2002 |
New nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinic | 1995 |
Treatment of common cutaneous herpes simplex virus infections.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chronic Disease; Diagnosis, Differential; Drug Costs; Fa | 2000 |
Acute and chronic herpes zoster. An ancient scourge yields to timely therapy.
Topics: 2-Aminopurine; Acute Disease; Acyclovir; Aged; Antiviral Agents; Chronic Disease; Famciclovir; Herpe | 2000 |
3 trials available for brl 42810 and Chronic Disease
| Article | Year |
|---|---|
Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study.
Topics: 2-Aminopurine; Acute Disease; Administration, Oral; Aged; Antiviral Agents; Bromodeoxyuridine; Chron | 2005 |
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
Topics: 2-Aminopurine; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Chronic Disease; Famciclovir; F | 2006 |
A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Carrier State; Chronic Disease; DNA, Viral; Doub | 1996 |
4 other studies available for brl 42810 and Chronic Disease
| Article | Year |
|---|---|
Physician survey for study of suppressive antiviral treatment to reduce chronic ocular disease and postherpetic neuralgia after herpes zoster ophthalmicus.
Topics: 2-Aminopurine; Acyclovir; Adult; Antiviral Agents; Attitude of Health Personnel; Chronic Disease; Fa | 2014 |
TREATMENT OF CHRONIC HERPESVIRAL DERMATITIS IN A CAPTIVE CHEETAH (ACINONYX JUBATUS) IN NAMIBIA.
Topics: 2-Aminopurine; Acinonyx; Animals; Antiviral Agents; Chronic Disease; Cryotherapy; Famciclovir; Herpe | 2015 |
Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia.
Topics: 2-Aminopurine; Acyclovir; Amitriptyline; Analgesics, Non-Narcotic; Antibodies, Viral; Antiviral Agen | 2003 |
Pharmacokinetics of famciclovir in subjects with chronic hepatic disease.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Adolescent; Adult; Biological Availability; Chromato | 1994 |